Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/Z1TS34 stock hub

BVMF/Z1TS34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/Z1TS34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

170.1B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/Z1TS34

In the news

Latest news · BVMF/Z1TS34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.8

P25 11.3P50 14.6P75 19.6

Trailing P/E12.2

P25 15.2P50 21.5P75 27.3

ROE67.7

P25 5.3P50 12.3P75 22.5

ROIC28.1

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/Z1TS34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	14,500
Employees Change	-300%
Employees Change Percent	-2.13
Enterprise value	BRL 205.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 170.1B
Price	BRL 24.97
Price currency	BRL
Rev Per Employee	3,429,007.31x
Sector	Healthcare
Sic	2834
Symbol	bvmf/Z1TS34
Website	https://www.zoetis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.2%
EV Earnings	14.77x
EV/EBIT	11.57x
EV/EBITDA	10.04x
EV/FCF	17.64x
EV/Sales	4.41x
FCF yield	6.86%
Forward P/E	11.81x
P/B ratio	10.08x
P/E ratio	12.2x
P/S ratio	3.42x
PE Ratio10 Y	36.4x
PE Ratio3 Y	30.14x
PE Ratio5 Y	34.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	38.12%
EBITDA Margin	42.74%
FCF margin	23.47%
Gross margin	71.84%
Gross Profit	BRL 35.7B
Gross Profit Growth	3.92%
Gross Profit Growth Q	1.44%
Gross Profit Growth3 Y	6.75%
Gross Profit Growth5 Y	7%
Net Income	BRL 13.9B
Net Income Growth	6.12%
Net Income Growth Q	-4.75%
Net Income Growth3 Y	8.86%
Net Income Growth5 Y	8.54%
Pretax Margin	35.1%
Profit Margin	28.03%
Profit Per Employee	BRL 961,316
ROA	15.52
Roa5y	13.76
ROCE	27.73
ROE	67.75
Roe5y	52.61
ROIC	28.1
Roic5y	28.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-55.2%
Cagr3y	-23.67%
Cagr5y	-14.37%
Div CAGR3	14.47%
Div CAGR5	17.9%
EPS Growth	9.63
EPS Growth Q	0.73
EPS Growth3 Y	11.4
EPS Growth5 Y	10.48
Revenue Growth	2.64x
Revenue Growth Q	1.89x
Revenue Growth3 Y	5.6x
Revenue Growth5 Y	6.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.65
Assets	BRL 79.1B
Cash	BRL 10.1B
Debt	BRL 48.3B
Debt EBITDA	BRL 2.21
Debt Equity	BRL 2.86
Debt FCF	BRL 4.14
Equity	BRL 16.9B
Interest Coverage	15.8
Liabilities	BRL 62.2B
Net Cash	BRL -38.1B
Net Cash By Market Cap	BRL -22.43
Net Debt EBITDA	BRL 1.8
Net Debt Equity	BRL 2.26
Net Debt FCF	BRL 3.27
Tangible Book Value	BRL -2.6B
Tangible Book Value Per Share	BRL -6.25
WACC	7.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.15
Inventory Turnover	1.09
Net Working Capital	BRL 12.9B
Quick ratio	1.68
Working Capital	BRL 23.1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.25%
Dividend Growth	1.58%
Dividend Growth Years	6%
Dividend per share	BRL 0.46
Dividend Years	7
Dividend Yield	1.85%
Ex Div Date	2026-04-17
Last Dividend	BRL 0.12
Payout Frequency	Quarterly
Payout Ratio	33.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-55.18%
200-day SMA	44.8
3Y total return	-55.54%
50-day SMA	37.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-53.96%
All Time High	88.5
All Time High Change	-71.79%
All Time High Date	2021-12-29
All Time Low	24.9
All Time Low Change	0.28%
All Time Low Date	2026-05-08
ATR	1.31
Beta	0.86
Ch YTD	-42.79
High	26.92
High52	60.61
High52 Date	2025-06-03
High52ch	-58.8%
Low	24.9
Low52	24.9
Low52 Date	2026-05-08
Low52ch	0.28%
Ma50ch	-34.11%
Price vs 200-day SMA	-44.26%
RSI	12.31
RSI Monthly	24.28
RSI Weekly	17.69
Sharpe ratio	-1.97x
Sortino ratio	-2.16
Total Return	5.1%
Tr YTD	-42.45
Tr1m	-33.38%
Tr1w	-28.29%
Tr3m	-39.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 19B
Operating Income Growth	5.73
Operating Income Growth Q	-2.84
Operating Income Growth3 Y	8.13
Operating Income Growth5 Y	7.65
Operating margin	38.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	418,397,996%
Shares Insiders	0.09%
Shares Institutions	105.51%
Shares Qo Q	-3.69%
Shares Yo Y	-3.25%
Short Ratio	2.91

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 11.2B
Average Volume	3,683.25x
Bv Per Share	40.12
CAPEX	BRL -2.9B
Ch1m	-33.59
Ch1w	-28.29
Ch1y	-55.65
Ch3m	-39.93
Ch3y	-56.62
Ch5y	-55.51
Ch6m	-37.34
Change	-6.3%
Change From Open	-7.24
Close	26.65
Days Gap	1.01
Depreciation Amortization	2,124,162,950
Dollar Volume	316,869.3
Earnings Date	2026-08-05
EBIT	BRL 19B
EBITDA	BRL 21.3B
EPS	BRL 31.86
F Score	6
FCF	BRL 11.7B
FCF EV Yield	5.67x
Financing CF	-10,605,601,925
Fiscal Year End	December
Founded	2,012
Graham Number	10.67843
Graham Upside	-57.23
Income Tax	BRL 3.5B
Investing CF	-3,296,970,200
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2026-03-31
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 17.47
Lynch Upside	-30.03
Ma150	42.07
Ma150ch	-40.64%
Ma20	35.45
Ma20ch	-29.56%
Net CF	772,075,300
Next Earnings Date	2026-08-05
Open	26.92
P FCF Ratio	14.57
P OCF Ratio	11.68
Payment Date	2026-06-09
Position In Range	3.47
Price Date	2026-05-08
Price EBITDA	BRL 8
Relative Volume	3.45x
Revenue	49,720,605,975x
SBC By Revenue	0.95x
Share Based Comp	474,721,975
Tax By Revenue	7.06x
Tax Rate	20.12%
Tr6m	-36.96%
Volume	12,690
Z Score	6.21

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/Z1TS34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.46 annual per share

Payout ratio

+33.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.9%

6 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2026-04-17

Performance

BVMF/Z1TS34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/Z1TS34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+105.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/Z1TS34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

12.3

Below 30: short-term oversold

Price vs 200-day MA

-44.3%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

-1.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/Z1TS34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/Z1TS34 stock rating?

bvmf/Z1TS34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/Z1TS34 analysis?

The full report lives at /stocks/bvmf/Z1TS34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/Z1TS34?

The latest report frames bvmf/Z1TS34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/Z1TS34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.